YPT31 Antibody

What is YPT31 and why is it an important research target?

YPT31 is a Rab family GTPase in Saccharomyces cerevisiae that functions as a molecular switch regulating vesicular trafficking. YPT31 and its paralog YPT32 (sharing >80% sequence identity) are essential for cellular viability when deleted together . These GTPases play key roles in:

• Exit from the trans-Golgi network

• Recycling from the plasma membrane through early endosomes to the Golgi

• Vesicle formation at the distal Golgi compartment

• Intracellular protein transport and secretion

YPT31/32 localize predominantly to punctate structures associated with Golgi membranes, consistent with their roles in Golgi-related trafficking . Their mammalian homologs include RAB11A, making this protein family evolutionarily conserved and significant for understanding fundamental trafficking mechanisms .

What are the primary applications of YPT31 antibodies in yeast research?

YPT31 antibodies are valuable tools in multiple experimental approaches:

These applications have been successfully employed to characterize YPT31's localization, interaction partners, and functions in vesicular transport .

How can I validate the specificity of YPT31 antibodies?

Validating antibody specificity is critical, especially considering the high homology between YPT31 and YPT32:

• Genetic controls:

  • Test antibody reactivity in Δypt31 deletion strains (should show no signal)

  • Compare signals in wild-type vs. Δypt32 strains (specific antibodies should show similar signals)

• Recombinant protein controls:

  • Test against purified recombinant YPT31 and YPT32

  • Perform competitive binding assays with purified proteins

• Cross-reactivity assessment:

  • Some anti-YPT31 antibodies have been documented not to cross-react with YPT32

  • Pre-absorb antibodies with recombinant YPT32 to improve specificity

• Tagged protein validation:

  • Compare antibody staining patterns with epitope-tagged YPT31 detected via tag antibodies

  • Confirm colocalization of signals in double-labeled experiments

For absolute specificity, consider using epitope-tagged versions of YPT31 and corresponding tag antibodies in parallel experiments .

How can I use YPT31 antibodies to distinguish between GTP-bound and GDP-bound forms of the protein?

YPT31, like other Rab GTPases, cycles between active (GTP-bound) and inactive (GDP-bound) states. Distinguishing these states requires specialized approaches:

• Effector pull-down assays:

  • Use GST-tagged effector proteins that specifically bind GTP-bound YPT31

  • Immunoblot the pulled-down fraction with YPT31 antibodies

  • The amount detected represents the active GTP-bound fraction

  • Research shows YPT31 interacts with effectors like Atg11 specifically in its GTP-bound form

• Conformation-specific immunoprecipitation:

  • Conduct immunoprecipitation in buffers containing either:

    • GTPγS (non-hydrolyzable GTP analog) to stabilize the active form

    • GDP to stabilize the inactive form

  • Compare interaction partners pulled down in each condition

  • Quantify differences in co-precipitated proteins

• Combined approaches:

  • Use the yeast two-hybrid system with nucleotide-restricted forms of YPT31 (Q72L, S27N, and N126I mutants)

  • Confirm interactions by co-immunoprecipitation with YPT31 antibodies

  • Validate with recombinant proteins in vitro

This combination of approaches can effectively distinguish nucleotide-dependent interactions of YPT31, as demonstrated in studies of its interactions with effector proteins .

How can I optimize colocalization studies with YPT31 antibodies?

Effective colocalization studies with YPT31 antibodies require careful planning and execution:

Choice of Markers:

• TGN markers: Sec7-DsRed has been successfully used with YPT31

• Endosomal markers: DsRed-FYVE domain proteins can help distinguish endosomal pools

• Vesicular markers: GFP-Rcy1 partially colocalizes with YPT31

• Secretory vesicle components: Sec2, Sec4, and Myo2 show temporal association with YPT31

Microscopy Optimization:

• Use high-resolution confocal microscopy with appropriate filter sets

• For YPT31 (detected by antibody) and GFP fusion proteins, use FITC filter for GFP and Texas Red filter for YPT31 antibody detection

• Z-stack imaging is critical as the Golgi in yeast appears as dispersed puncta

Quantitative Analysis:

• Measure colocalization using established coefficients (Pearson's or Mander's)

• Consider the dynamic nature of YPT31 localization during vesicle formation

• For temporal studies, fix cells at defined intervals after synchronization

Controls and Validation:

• Single-labeled samples to rule out bleed-through

• Cells lacking the protein of interest (deletion strains)

• Compare results with published patterns of YPT31/32 localization

• Note that YPT31 and YPT32 show subtle differences in localization patterns, with YPT32 more prominent in compartments within the bud

These approaches have enabled researchers to characterize the dynamic localization of YPT31 in relation to other trafficking components .

How can YPT31 antibodies be used to study the role of YPT31 in protein recycling and ubiquitination?

YPT31/32 and their effector Rcy1 regulate ubiquitination of recycling proteins like the v-SNARE Snc1 . Antibody-based approaches to study this include:

Ubiquitination Assays:

• Express HA-Snc1-Myc-Ub in appropriate yeast strains (wild-type, ypt31Δ/32ts, rcy1Δ)

• Immunoprecipitate with anti-HA antibodies

• Detect ubiquitinated species by immunoblotting with anti-Myc antibodies

• Compare ubiquitination levels between strains and conditions

Research shows that in both ypt31Δ/32ts and rcy1Δ mutant cells, Snc1-Ub conjugate levels are significantly lower than in wild-type cells, confirming YPT31/32's role in this process .

Interaction Studies:

• Use YPT31 antibodies to immunoprecipitate the protein complex

• Probe for F-box proteins like Rcy1 by western blotting

• Test nucleotide-dependence of these interactions

• Compare results between wild-type and mutant forms of YPT31/32

Localization Analysis:

• Perform immunofluorescence of YPT31 and recycling cargo proteins

• Track changes in localization in ubiquitination-defective mutants

• Quantify colocalization coefficients under different conditions

These methodologies have revealed that YPT31/32 play crucial roles in the ubiquitination and proper recycling of proteins like Snc1 from the plasma membrane through early endosomes to the Golgi .

What experimental approaches can distinguish the functions of YPT31 from YPT32?

Despite their high sequence similarity (>80%), YPT31 and YPT32 may have subtle functional differences. These approaches can help differentiate them:

Comparative Localization:

• Use specific antibodies or differentially tagged versions of each protein

• Quantify their distribution across cellular compartments

• Research indicates YPT32 is more prominent in compartments within the bud compared to YPT31

Genetic Complementation Analysis:

• In strains where one gene is deleted and the other is depleted, analyze compensation mechanisms

• Use temperature-sensitive or conditional alleles (like ypt31-1)

• Monitor effects on:

  • Protein secretion (invertase assay)

  • Vacuolar protein maturation

  • Golgi morphology

Interaction Partner Profiling:

• Perform parallel immunoprecipitations with specific antibodies for each protein

• Identify binding partners by mass spectrometry

• Compare interaction profiles quantitatively

GTPase-Specific Assays:

• Measure nucleotide binding/hydrolysis rates of purified proteins

• Analyze how mutations in conserved domains (like K127N in YPT31) affect function

• Compare functional consequences in cellular assays

These approaches can reveal the evolutionary specialization of these duplicated Rab GTPases while maintaining system redundancy for essential functions .

How can YPT31 antibodies be used to analyze vesicle formation at the trans-Golgi network?

YPT31/32 play critical roles in vesicle formation at the trans-Golgi network (TGN). Antibody-based approaches to study this process include:

Temporal Analysis of Vesicle Formation:

• Synchronize cells using temperature-sensitive secretory mutants

• Release from block and fix at short intervals (30 seconds to 5 minutes)

• Immunostain for YPT31 and markers of vesicle formation (Sec2, Sec4)

• Quantify the temporal sequence of protein recruitment

Research shows that Sec2 appears on YPT31-containing compartments approximately 2 seconds prior to vesicle separation, while Sec4 appears about 1 second before separation .

Ultrastructural Analysis:

• Perform immuno-electron microscopy with gold-labeled YPT31 antibodies

• Identify YPT31-positive structures at different stages of vesicle formation

• Correlate with other markers of the secretory pathway

• In ypt31/32 mutants, aberrant Golgi structures accumulate instead of secretory vesicles

Inhibition Studies:

• Use temperature-sensitive alleles (ypt31-1) to rapidly inactivate function

• Fix cells at early timepoints after shift (30 minutes)

• Examine Golgi morphology changes by immunofluorescence and electron microscopy

• Research shows rapid accumulation of Golgi-like cisternae upon YPT31/32 inactivation

Cargo Transit Analysis:

• Track specific cargo proteins through the secretory pathway

• Correlate with YPT31 localization

• In ypt31/32 mutants, secretory proteins like invertase show defective export

These approaches have revealed that YPT31/32 function is required for vesicle formation at the trans-Golgi, with rapid phenotypic consequences when this function is disrupted .

How can I troubleshoot weak or non-specific signals when using YPT31 antibodies?

When facing challenges with YPT31 antibody applications, these systematic approaches can help:

For Weak Signals:

For Non-specific Signals:

Validation Approaches:

• Compare results with published patterns of YPT31 localization

• Use epitope competition with purified YPT31 protein

• Consider comparing multiple antibodies from different sources

• For critical experiments, confirm results with epitope-tagged YPT31

These troubleshooting approaches have helped researchers obtain specific and reliable results when studying YPT31 in various applications .

What controls are essential when studying YPT31 in vesicular transport assays?

When investigating YPT31's role in vesicular transport, these controls are crucial for reliable interpretation:

Genetic Controls:

• Δypt31 strain (to confirm antibody specificity)

• Δypt32 strain (to assess functional redundancy)

• ypt31-1 temperature-sensitive mutant (for acute inactivation studies)

• Nucleotide-binding mutants (e.g., YPT31-Q72L, S27N)

Compartment Markers:

• Early Golgi: Ypt1

• Trans-Golgi: Sec7

• Secretory vesicles: Sec4

• Endosomes: FYVE-domain proteins

• Plasma membrane: appropriate PM markers

Cargo Controls:

• Bulk secretory pathway: invertase

• Vacuolar sorting: carboxypeptidase Y (CPY)

• Recycling pathway: Snc1

• Specialized cargo: α-factor, Kex2

Biochemical Controls:

• GTP vs. GDP-loaded recombinant YPT31

• Dominant-active (GTP-locked) and dominant-negative (GDP-locked) mutants

• Appropriate nucleotides in buffers (GTP, GDP, or non-hydrolyzable analogs)

Timing Controls:

• Synchronized cultures

• Multiple timepoints after induction/block release

• Early fixation times to capture transient intermediates

These controls enable researchers to distinguish direct YPT31 effects from indirect consequences and to properly position YPT31 function in the secretory and recycling pathways .

How should YPT31 antibodies be validated for studying its role in autophagy?

YPT31 has connections to selective autophagy through the Ypt/Rab GTPase module . When validating antibodies for autophagy studies, consider:

Specificity Validation:

• Test reactivity in autophagy-inducing conditions (nitrogen starvation)

• Compare staining patterns in wild-type and autophagy-defective (atg) mutants

• Verify specificity against recombinant YPT31 protein

• Confirm no cross-reactivity with YPT32 in autophagy conditions

Functional Validation:

• Verify antibody detection of YPT31-GTP vs. YPT31-GDP forms

• Confirm ability to detect YPT31 interactions with autophagy proteins (e.g., Atg11)

• Test antibody compatibility with autophagy fixation methods

• Validate in colocalization studies with autophagy markers

Technical Validation:

• Optimize fixation methods to preserve autophagosomal structures

  • PFA fixation (3-4%) is preferred over methanol

  • Gentle permeabilization to preserve membrane integrity

• Test antibody performance in various applications:

  • Immunofluorescence of autophagy-induced cells

  • Western blotting of lysates from starved/non-starved cells

  • Immunoprecipitation in autophagy conditions

Controls to Include:

• Genetic controls:

  • atg1Δ, atg11Δ mutants (blocks autophagy)

  • ypt1 mutants (affects early autophagy steps)

• Condition controls:

  • Fed vs. starved states

  • Rapamycin treatment (induces autophagy)

• Protein interaction controls:

  • Verify YPT31-Atg11 interaction specificity with YPT31-GTP

  • Compare with other Ypt/Rab proteins

These validation steps ensure that YPT31 antibodies reliably detect the protein in autophagy-relevant contexts and can accurately report on its functions in this pathway .

How can YPT31 antibodies be used to study the relationship between vesicle trafficking and ubiquitination?

YPT31/32 and their effector Rcy1 regulate ubiquitination of recycling proteins , providing an important model system for studying how trafficking and ubiquitination intersect:

Experimental Approaches:

• Combined Ubiquitination and Localization Analysis:

  • Express HA-Snc1-Myc-Ub in yeast cells

  • Perform immunoprecipitation with anti-HA antibodies

  • Analyze ubiquitinated species by anti-Myc western blotting

  • In parallel, perform immunofluorescence to track Snc1 localization

  • Compare wild-type with ypt31Δ/32ts cells

  • Research shows both ubiquitination and proper recycling of Snc1 are defective in ypt31Δ/32ts mutants

• Site-Specific Ubiquitination Analysis:

  • Generate Snc1-K63R mutant (defective in K63-linked ubiquitination)

  • Track its trafficking using immunofluorescence with YPT31 colocalization

  • Compare recycling efficiency with wild-type Snc1

  • Data indicates Snc1-K63R is defective in endosome-to-Golgi transport

• Interaction Network Mapping:

  • Use YPT31 antibodies for immunoprecipitation

  • Identify ubiquitination machinery components in the precipitate

  • Compare results in different genetic backgrounds

  • Analyze GTP-dependence of these interactions

• In vitro Reconstitution:

  • Purify components of the YPT31-Rcy1-Snc1 system

  • Set up in vitro ubiquitination assays

  • Use antibodies to detect reaction products and intermediates

These approaches have established that YPT31/32 GTPases integrate intracellular trafficking with ubiquitination processes, suggesting a new regulatory mechanism for membrane protein recycling .

What approaches can be used to study the interactions between YPT31 and the TRAPPII complex?

The TRAPPII complex acts as a guanine nucleotide exchange factor (GEF) for YPT31/32 . Studying this interaction requires specialized approaches:

Structural and Biochemical Methods:

• GEF Activity Assays:

  • Purify TRAPPII complex components (e.g., Trs120, Trs130)

  • Measure nucleotide exchange on recombinant YPT31

  • Use YPT31 antibodies to immunoprecipitate and identify associated GEF activity

  • Research shows TRAPPII specifically activates YPT31/32 in the trans-Golgi network

• Binding Interaction Analysis:

  • Perform co-immunoprecipitation with YPT31 antibodies

  • Test interaction with various TRAPPII components

  • Compare binding of wild-type vs. nucleotide-restricted YPT31 mutants

  • Analyze how mutations in TRAPPII components affect binding

• Structural Analysis:

  • Compare YPT31-GDI complex with YPT31-TRAPPII complex

  • Unlike YPT1, YPT32's loop β2-β3 doesn't change upon binding to TRAPPII

  • This structural difference may explain specific activation mechanisms

Functional Approaches:

• Mutant Analysis:

  • Test genetic interactions between ypt31/32 and trs120/trs130 mutants

  • Perform growth assays at various temperatures

  • Research shows YPT31 suppresses autophagy defects in trs130 and trs65 mutants

• Localization Studies:

  • Track colocalization of YPT31 and TRAPPII components

  • Use high-resolution microscopy to visualize activation events

  • Monitor changes in colocalization patterns during vesicle formation

• Cisternal Maturation Analysis:

  • Study how TRAPPII-mediated activation of YPT31/32 drives Golgi maturation

  • Monitor sequential recruitment of trafficking factors

  • Changes in YPT1 and YPT31 activity affect early-to-transitional and transitional-to-late Golgi progression, respectively

These approaches have revealed the specific mechanism by which TRAPPII activates YPT31/32 to control vesicle formation at the trans-Golgi network .

How can YPT31 antibodies help distinguish membrane-bound from cytosolic pools of the protein?

YPT31, like other Rab GTPases, cycles between membrane-bound and cytosolic states. Differentiating these pools requires specialized antibody-based approaches:

Subcellular Fractionation:

• Prepare cell lysates without detergents

• Separate cytosolic (S100) and membrane (P100) fractions by ultracentrifugation

• Analyze fractions by western blotting with YPT31 antibodies

• Include controls: cytosolic marker (phosphoglycerate kinase) and membrane marker (Dpm1)

• Research indicates a significant part of YPT31 is located in Golgi-enriched membrane fractions

Differential Extraction:

• Prepare multiple aliquots of cell lysates

• Treat with increasing concentrations of detergents or chaotropic agents

• Centrifuge to separate soluble and insoluble fractions

• Analyze YPT31 distribution by immunoblotting

• Membrane-integrated proteins require stronger extraction conditions

Density Gradient Analysis:

• Separate cellular components on sucrose density gradients

• Collect fractions and analyze by western blotting

• Compare YPT31 distribution to known membrane markers

• Cytosolic YPT31 will appear in different fractions than membrane-bound pools

Immunofluorescence Approaches:

• Use gentle permeabilization to preserve membrane structures

• Stain with YPT31 antibodies and membrane markers

• Perform quantitative image analysis to measure:

  • Signal overlap with membrane compartments

  • Diffuse vs. punctate staining patterns

  • Relative intensity in different cellular regions

These methodologies have been used to demonstrate that YPT31 associates significantly with Golgi membranes, consistent with its role in trans-Golgi trafficking .